Clinical Trial Update: Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating individual dose adjustment of low-molecular-weight heparin by a thromodynamics test was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Pirogov Russian National Research Medical University | Conditions: Venous Thromboembolism | Phase 4 | Status: TERMINATED